HKSE Consumer Defensive Household & Personal Products 2367.HK

Giant Biogene Holding Co., Ltd.

$ 25.52 -0.78 %

Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.

CEO: Jianya Yan - https://www.xajuzi.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ 161.83

Loading data...

2367.HK vs S&P500

Loading data...

No data available.

Quick ratio

10.78

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

12.21

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

2.09

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

20.06 %

is generally considered excellent, indicating that the company is generating strong profits with its equity.

ROIC

17.19 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

7.59

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.00

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

1.35

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

65.67 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
4 indicates moderate financial health
Altman score
19.19 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
7.88 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.00 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.